Showing results (1691-1700 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|March 11, 2016
Convection-enhancement delivery of liposomal formulation of oxaliplatin shows less toxicity than oxaliplatin yet maintains a similar median survival time in F98 glioma-bearing rat modelMinghan Shi, David Fortin, Benoit Paquette, et al.
Investigational New Drugs|July 1, 1989
Phase II trial of spirogermanium in advanced non-small cell lung cancer. An Illinois Cancer Council StudyT E Lad, R R Blough, M Evrard, et al.
Investigational New Drugs|December 6, 2014
Phase I study of XL281 (BMS-908662), a potent oral RAF kinase inhibitor, in patients with advanced solid tumorsMark A Dickson, Michael S Gordon, Gerald Edelman, et al.
Investigational New Drugs|August 16, 2015
Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignanciesAmit Mahipal, Dave Shibata, Erin Siegel, et al.
Investigational New Drugs|August 18, 2015
Ulcerative colitis in a patient with non-small-cell lung cancer receiving bevacizumabMidori Tanaka, Hidenobu Ishii, Koichi Azuma, et al.
Investigational New Drugs|November 14, 2015
Coibamide A, a natural lariat depsipeptide, inhibits VEGFA/VEGFR2 expression and suppresses tumor growth in glioblastoma xenograftsJeffrey D Serrill, Xuemei Wan, Andrew M Hau, et al.
Investigational New Drugs|October 23, 2015
Fluorouracil, leucovorin and irinotecan associated with aflibercept can induce microscopic colitis in metastatic colorectal cancer patientsFrançois Ghiringhelli, Julie Vincent, Françoise Beltjens, et al.
Investigational New Drugs|October 23, 2015
Effects of mTOR inhibitors and cytoskeletal-directed agents alone and in combination against normal and neoplastic hematopoietic cells in vitroMatthew Trendowski, Timothy D Christen, Antoaneta A Andonova, et al.
Investigational New Drugs|November 3, 2015
Identification of a novel compound (β-sesquiphellandrene) from turmeric (Curcuma longa) with anticancer potential: comparison with curcuminAmit Kumar Tyagi, Sahdeo Prasad, Wei Yuan, et al.
Investigational New Drugs|November 13, 2015
7-formyl-10-methylisoellipticine, a novel ellipticine derivative, induces mitochondrial reactive oxygen species (ROS) and shows anti-leukaemic activity in miceEileen G Russell, Jianfeng Guo, Elaine C O'Sullivan, et al.
Pageof 372